ERBB2 and neoplasm: In the current study, Grade 3 tumours were recorded in a substantial percentage of TNBC (72.7%) and HER2 enriched (61.5%) cases, while the majority of Luminal B tumours were categorised as Grade 2 (70.8%) and (40%) of Grade 1 tumours were found in the Luminal A subtype group.